Date	Chamber	Action
1/8/2019	House	Session Sine Die

Statutes Amended In Order of Appearance

410 ILCS 620/16.2 new

410 ILCS 620/16.3 new

Synopsis As Introduced
Amends the Illinois Food, Drug and Cosmetic Act. Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration. Provides that within 30 days after such notifications, prescription drug manufacturers shall report specified information to State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly. Provides that failure to report such information shall result in a specified civil penalty. Requires the General Assembly to conduct an annual public hearing on aggregate trends in prescription drug pricing. Provides that if the manufacturer of a prescription drug or its agent meets or otherwise communicates with a prescriber for the purpose of marketing a drug, then the manufacturer or its agent shall disclose to the prescriber if any ingredient in the drug it is marketing is known to pose a risk of dependency in humans. Makes other changes.

Actions 

Date	Chamber	Action
12/15/2016	House	Prefiled with Clerk by Rep. Mary E. Flowers
1/11/2017	House	First Reading
1/11/2017	House	Referred to Rules Committee
1/25/2017	House	Assigned to Health Care Licenses Committee
1/31/2017	House	Added Co-Sponsor Rep. Silvana Tabares
1/31/2017	House	Added Co-Sponsor Rep. Thaddeus Jones
2/23/2017	House	Added Co-Sponsor Rep. Camille Y. Lilly
2/28/2017	House	Added Chief Co-Sponsor Rep. Emanuel Chris Welch
3/14/2017	House	Added Co-Sponsor Rep. Natalie A. Manley
3/31/2017	House	Rule 19(a) / Re-referred to Rules Committee
1/8/2019	House	Session Sine Die

Back To Top